Global Talent visa
Future of MHRA uncertain amid Brexit-fuelled shake up
Trade unions and regulatory experts warn that budget and staff cuts may lead to drug approval delays or the UK regulator simply rubber-stamping EMA decisions
MHRA outlines two-year delivery plan with ‘patient first’ focus
New delivery plan also outlines strategy for UK regulatory body following Brexit
Leaders in Pharma: Danielle Portnik
In this episode of Impetus Digital's Leaders in Pharma podcast, I sit down with Danielle Portnik. She is currently the Regional Business Director for International with Ambry Genetics.
The UK reasserts that the AZ vaccine is ‘effective across all age groups’
Germany's draft guidance does not recommend the vaccine for people over 65
The Brexit clock is counting down and time is running out
What businesses need to know about post-Brexit immigration
UK contributes £210m towards COVID-19 vaccine efforts
Prime Minister Boris Johnson also tests positive for coronavirus
UK ramps up measures to combat coronavirus spread
New advice encourages ‘social-distancing’ as cases expected to soar
UK officially moves into ‘delay’ phase of coronavirus plan
New measures includes broader self-isolation advice
UK government considers move into ‘delay’ phase of coronavirus response plan
Proposed emergency measures could include 'social distancing'
Doctors worried NHS is unprepared for coronavirus as government unveils action plan
Concerns raised as government reveals key planning document
NHS reliance on ‘short-term measures’ has made it financially unstable, auditors report
Quick fixes are draining funding for long-term investment
It’s Brexit day – now comes the really hard stuff
Months of trade negotiations between UK and EU lie ahead